↓ Skip to main content

Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity

Overview of attention for article published in BMC Complementary Medicine and Therapies, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
90 Mendeley
Title
Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity
Published in
BMC Complementary Medicine and Therapies, October 2013
DOI 10.1186/1472-6882-13-273
Pubmed ID
Authors

Vikas Kumar, Danish Ahmed, Amita Verma, Firoz Anwar, Mohammed Ali, Mohd Mujeeb

Abstract

Aegle marmelos (L.) Corr. (Rutaceae), commonly known as bael, is used to treat fevers, abdomen pain, palpitation of the heart, urinary troubles, melancholia, anorexia, dyspepsia, diabetes and diarrhea in Indian traditional systems of medicine. The object of the present study was to evaluate the antidiabetic, antihyperlipidemic and antioxidant oxidative stress of umbelliferone β-D-galactopyranoside (UFG) from stem bark of Aegle marmelos Correa. in STZ (streptozotocin) induced diabetic rat.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 90 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 17%
Student > Master 9 10%
Researcher 8 9%
Professor > Associate Professor 6 7%
Student > Bachelor 4 4%
Other 14 16%
Unknown 34 38%
Readers by discipline Count As %
Medicine and Dentistry 14 16%
Agricultural and Biological Sciences 12 13%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Chemistry 4 4%
Nursing and Health Professions 3 3%
Other 8 9%
Unknown 39 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2022.
All research outputs
#3,991,775
of 22,851,489 outputs
Outputs from BMC Complementary Medicine and Therapies
#757
of 3,632 outputs
Outputs of similar age
#37,433
of 211,820 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#19
of 99 outputs
Altmetric has tracked 22,851,489 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,632 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.